Seasoned healthcare executive will help advise ZappRx leadership as the company continues to innovate and grow
Boston, Mass., February 9, 2018 – ZappRx, a digital health company that reduces the administrative burden associated with prescribing specialty medications, is pleased to welcome Jay Silverstein as the newest advisor to its Board of Directors. In his role, Silverstein will provide strategic consultation and expertise to help carry the company’s mission forward.
Mr. Silverstein joins the board with over 25 years of healthcare and digital health experience having worked at companies like UnitedHealthcare and Medco. Silverstein currently serves as an advisor to the board of PICKWELL INC, where he served as the CEO in 2014. As a veteran in the healthcare industry, Silverstein has established a strong reputation as a thought leader. He has played an instrumental role in the development of some of the most significant and impactful paradigm shifts in the health sector involving Point-of-Service Plans, mainstream insurance, database driven preventive medicine, physician report cards and the elimination of medical necessity review.
“Since first learning about the work Zoë and the ZappRx team is doing to rectify the antiquated specialty pharmaceutical prescribing and prior authorization process, I was instantly intrigued and knew they were on the right path,” said Mr. Silverstein. “By joining the company as one of its advisor’s, I will have a seat at the table of a very promising company and solution to this increasingly important and challenging issue. I’m looking forward to rolling my sleeves up and to watching this very innovative company strive.”
“We could not be more excited to welcome Jay to our Board of Directors,” said Zoë Barry, ZappRx CEO and founder. “Much of our success to date has been predicated on the deep expertise and business acumen of our board, and I have no doubt that Jay’s addition will strengthen our position in the market and ability to affect real and meaningful change.”
Silverstein joins an already impressive group of Advisors to the Board at ZappRx, including Simon Kennedy, Mike Wyzga, and Scott McKay.